Search

everythinglearnresearchcommunity

for

Search:↓

Injectable treatments can effectively and safely improve hair growth in adults with androgenetic alopecia.

Ishophloroglucin A from Ishige okamurae may be a natural alternative for treating hair loss by inhibiting 5α-reductase and promoting hair growth.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

Gp₄G promotes hair growth and improves skin health.

Smart microneedles improve hair loss treatment by delivering drugs precisely with fewer side effects.

Spironolactone improved symptoms in women with hormonal imbalances and had few side effects.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

TFC-loaded microneedles effectively promote hair regrowth in androgenetic alopecia.

Minoxidil is an effective and safe treatment for common hair loss when applied to the skin, but more research is needed for optimal use.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

A combination of IGF-1 and EGF promotes hair growth in Angora rabbits.

The hydrogel improves hair growth treatment by enhancing drug delivery and promoting follicle repair.

Plant-derived nanoparticles from Polygoni Multiflori Radix promote hair growth better than Minoxidil by affecting androgen pathways.

A reliable method was developed to measure aristolochic acid-I in rat blood.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

Self-assembling peptide hydrogels effectively deliver drugs locally, enhancing treatment and reducing side effects.

Clascoterone may be an effective topical treatment for hair loss.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

Targeted nanomodulators can rejuvenate cells and promote hair growth in androgenetic alopecia.

A new microneedle system with minoxidil nanoparticles effectively promotes hair regrowth with fewer side effects.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Botulinum toxin A does not significantly improve hair density or thickness in androgenetic alopecia.